- First quarter 2013 adjusted net income was $50 million or $0.27 per
share, down $0.09 from first quarter 2012; GAAP net income was $41
million or $0.22 per share, down $0.12
- First quarter 2013 revenue was $879 million, down $46 million from
first quarter 2012
- Xylem maintains FY 2013 EPS of $1.79-$1.89 on revenue midpoint of
$3.9 billion

Company Website:
http://www.xyleminc.com
WHITE PLAINS, N.Y. -- (Business Wire)
Xylem Inc. (NYSE: XYL), a leading global water technology company
dedicated to solving the world’s most challenging water issues, today
reported first quarter 2013 net income of $41 million, or $0.22 per
share. Adjusted net income was $50 million, or $0.27 per share,
excluding the impact of special items that include restructuring and
realignment charges, and special tax items. First quarter revenue was
$879 million, down $46 million from the first quarter 2012, reflective
of on-going European economic challenges, U.S. industrial weakness and
lower shipments for treatment projects. First quarter 2013 adjusted
operating margins were down 230 basis points, down 320 basis points as
reported, resulting from lower volume, acquisition costs and continued
investments in growth initiatives.
"We were pleased to deliver earnings in line with our expectations
despite weaker revenue for the quarter than we had anticipated,” said
Gretchen McClain, president and chief executive officer of Xylem Inc.
“We’re addressing continued market challenges in several key regions of
the world, especially Europe, and are taking assertive cost actions to
reposition ourselves as a more competitive and efficient organization,
and to create more value for our customers. We continue to pursue
attractive acquisitions that will help to strengthen our portfolio.
During the first quarter, we completed two acquisitions – PIMS, which
bolsters our attractive service business; and MultiTrode, which enhances
our global water and wastewater monitoring and control offering.”
“Exciting new product launches are winning in the market place, leading
to share gains in key market segments,” McClain said. “We were proud to
launch several innovative products this quarter, including new
dewatering solutions from our Godwin and Flygt brands, as well as new
analytical lab instruments from our YSI and OI Analytical brands. As we
look ahead to the remainder of 2013, we are focused on introducing
additional new products, and continuing to expand geographically.
Through these and other customer-focused solutions, we will continue to
position Xylem as a global leader in the water industry.”
Xylem affirms full-year guidance, forecasting full-year 2013 revenue
growth of 3 to 4 percent to approximately $3.9 billion. Full-year 2013
adjusted net income is forecast to grow 1 to 7 percent to $333 to $352
million, for adjusted earnings per share of $1.79 to $1.89 per share.
The company anticipates that restructuring and realignment costs will
range from $60 to $70 million for the year.
First Quarter Segment Results
Water Infrastructure
Xylem’s Water Infrastructure segment consists of its businesses serving
clean water delivery, wastewater transport and treatment, dewatering and
analytical instrumentation.
-
First quarter 2013 revenue was $551 million, down 6 percent compared
with the first quarter 2012, reflecting U.S. industrial weakness,
European economic challenges and decreased treatment shipments.
-
First quarter adjusted segment operating income was $52 million.
Adjusted operating margin was 9.4 percent, reflecting lower volumes,
acquisition impacts and continued investments.
Applied Water
Xylem’s Applied Water segment consists of its portfolio of businesses in
residential and commercial building services, industrial and
agricultural applications.
-
First quarter 2013 revenue was $345 million, down 3 percent compared
with the first quarter 2012, reflecting weak industrial demand and
European economic challenges, offset by strength in U.S. residential
and agricultural end markets.
-
First quarter adjusted segment operating income was $42 million, up 2
percent versus the same period in 2012. Adjusted operating margin was
12.2 percent, reflecting strong operational performance.
Supplemental information on Xylem’s first quarter earnings and
reconciliations for certain non-GAAP items are posted at
investors.xyleminc.com.
About Xylem
Xylem (NYSE: XYL) is a leading global water technology provider,
enabling customers to transport, treat, test and efficiently use water
in public utility, residential and commercial building services,
industrial and agricultural settings. The company does business in more
than 150 countries through a number of market-leading product brands,
and its people bring broad applications expertise with a strong focus on
finding local solutions to the world’s most challenging water and
wastewater problems. Xylem is headquartered in White Plains, N.Y., with
2012 annual revenues of $3.8 billion and approximately 12,700 employees
worldwide. In 2012, Xylem was named to the Dow Jones Sustainability
World Index for advancing sustainable business practices and solutions
worldwide.
The name Xylem is derived from classical Greek and is the tissue that
transports water in plants, highlighting the engineering efficiency of
our water-centric business by linking it with the best water
transportation of all -- that which occurs in nature. For more
information, please visit us at www.xyleminc.com.
Forward-Looking Statements
This document contains information that may constitute “forward-looking
statements.” Forward-looking statements by their nature address matters
that are, to different degrees, uncertain. Generally, the words
“anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,”
“believe,” “target” and similar expressions identify forward-looking
statements, which generally are not historical in nature. However, the
absence of these words or similar expressions does not mean that a
statement is not forward-looking.
These forward-looking statements include, but are not limited to,
statements about the separation of Xylem Inc. (the “Company”) from ITT
Corporation in 2011, capitalization of the Company, future strategic
plans and other statements that describe the Company’s business
strategy, outlook, objectives, plans, intentions or goals, and any
discussion of future operating or financial performance. All statements
that address operating performance, events or developments that we
expect or anticipate will occur in the future — including statements
relating to orders, sales, operating margins and earnings per share
growth, and statements expressing general views about future operating
results — are forward-looking statements.
Caution should be taken not to place undue reliance on any such
forward-looking statements because they involve risks, uncertainties and
other factors that could cause actual results to differ materially from
those expressed or implied in, or reasonably inferred from, such
statements. The Company undertakes no obligation to publicly update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by law. In
addition, forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially from
the Company’s historical experience and our present expectations or
projections. These risks and uncertainties include, but are not limited
to, those set forth in Item 1A in our Annual Report on Form 10-K, and
those described from time to time in subsequent reports filed with the
Securities and Exchange Commission.
|
|
| |
|
| |
XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited)
(in millions, except per share data)
| | | | | | |
| | | | | |
|
| For the three months ended March 31, |
|
| 2013 | | |
2012
|
|
Revenue
| | | $ | 879 | | | |
$
|
925
| |
|
Cost of revenue
| | | 545 |
| | |
562
|
|
|
Gross profit
| | | 334 | | | |
363
| |
|
Selling, general and administrative expenses
| | | 236 | | | |
231
| |
|
Research and development expenses
| | | 26 | | | |
28
| |
|
Restructuring charges
| | | 5 | | | |
—
| |
|
Separation costs
| | | 1 |
| | |
5
|
|
|
Operating income
| | | 66 | | | |
99
| |
|
Interest expense
| | | 13 | | | |
14
| |
|
Other non-operating (expense), net
| | | (2 | ) | | |
(1
|
)
|
|
Income before taxes
| | | 51 | | | |
84
| |
|
Income tax expense
| | | 10 |
| | |
21
|
|
|
Net income
| | | $ | 41 |
| | |
$
|
63
|
|
|
Earnings per share:
| | | | | | |
|
Basic
| | | $ | 0.22 | | | |
$
|
0.34
| |
|
Diluted
| | | $ | 0.22 | | | |
$
|
0.34
| |
|
Weighted average number of shares:
| | | | | | |
|
Basic
| | | 185.8 | | | |
185.4
| |
|
Diluted
| | | 186.4 | | | |
185.9
| |
|
Dividends declared per share
| | | $ | 0.1164 | | | |
$
|
0.1012
| |
| | | | | | | | | |
|
|
|
| |
|
| |
XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(in millions, except per share amounts)
| | | | | | |
| | | | | |
|
|
|
|
| March 31, 2013 | | |
December 31, 2012
|
| | |
(Unaudited)
| | | |
| ASSETS | | | | | | |
|
Current assets:
| | | | | | |
|
Cash and cash equivalents
| | | $ | 375 | | | |
$
|
504
| |
|
Receivables, less allowances for discounts and doubtful accounts of
$27 and $34 in 2013 and 2012, respectively
| | | 767 | | | |
776
| |
|
Inventories, net
| | | 461 | | | |
443
| |
|
Prepaid and other current assets
| | | 111 | | | |
110
| |
|
Deferred income tax assets
| | | 43 |
| | |
41
|
|
|
Total current assets
| | | 1,757 | | | |
1,874
| |
|
Property, plant and equipment, net
| | | 474 | | | |
487
| |
|
Goodwill
| | | 1,669 | | | |
1,647
| |
|
Other intangible assets, net
| | | 504 | | | |
484
| |
|
Other non-current assets
| | | 185 |
| | |
187
|
|
| Total assets | | | $ | 4,589 |
| | |
$
|
4,679
|
|
| LIABILITIES AND STOCKHOLDERS’ EQUITY | | | | | | |
|
Current liabilities:
| | | | | | |
|
Accounts payable
| | | $ | 309 | | | |
$
|
332
| |
|
Accrued and other current liabilities
| | | 406 | | | |
443
| |
|
Short-term borrowings and current maturities of long-term debt
| | | 6 |
| | |
6
|
|
|
Total current liabilities
| | | 721 | | | |
781
| |
|
Long-term debt
| | | 1,199 | | | |
1,199
| |
|
Accrued postretirement benefits
| | | 397 | | | |
400
| |
|
Deferred income tax liabilities
| | | 179 | | | |
173
| |
|
Other non-current accrued liabilities
| | | 53 |
| | |
52
|
|
| Total liabilities | | | 2,549 |
| | |
2,605
|
|
|
Commitments and contingencies (Note 17)
| | | | | | |
|
Stockholders’ equity:
| | | | | | |
|
Common Stock – authorized 750.0 shares, par value $0.01 per share:
| | | | | | |
|
Issued 186.3 shares and 186.2 shares in 2013 and 2012, respectively
| | | 2 | | | |
2
| |
|
Capital in excess of par value
| | | 1,711 | | | |
1,706
| |
|
Retained earnings
| | | 283 | | | |
264
| |
|
Treasury stock – at cost 1.0 shares and 0.5 shares in 2013 and 2012,
respectively
| | | (28 | ) | | |
(13
|
)
|
|
Accumulated other comprehensive income
| | | 72 |
| | |
115
|
|
| Total stockholders’ equity | | | 2,040 |
| | |
2,074
|
|
| Total liabilities and stockholders’ equity | | | $ | 4,589 |
| | |
$
|
4,679
|
|
| | | | | | | | | |
|
|
|
| |
|
| |
XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(in millions)
| | | | | | |
| | | | | |
|
| For the three months ended March 31, |
|
| 2013 |
|
|
2012
|
| Operating Activities | | | | | | |
|
Net income
| | | $ | 41 | | | |
$
|
63
| |
|
Adjustments to reconcile net income to net cash provided by
operating activities:
| | | | | | |
|
Depreciation
| | | 25 | | | |
23
| |
|
Amortization
| | | 12 | | | |
11
| |
|
Share-based compensation
| | | 6 | | | |
5
| |
|
Restructuring charges
| | | 5 | | | |
—
| |
|
Payments for restructuring
| | | (4 | ) | | |
—
| |
|
Changes in assets and liabilities (net of acquisitions):
| | | | | | |
|
Changes in receivables
| | | 1 | | | |
7
| |
|
Changes in inventories
| | | (29 | ) | | |
(31
|
)
|
|
Changes in accounts payable
| | | (8 | ) | | |
14
| |
|
Other, net
| | | (29 | ) | | |
(31
|
)
|
| Net Cash – Operating activities | | | 20 |
| | |
61
|
|
| Investing Activities | | | | | | |
|
Capital expenditures
| | | (30 | ) | | |
(31
|
)
|
|
Acquisitions, net of cash acquired
| | | (78 | ) | | |
—
| |
|
Proceeds from the sale of property, plant and equipment
| | | 3 |
| | |
2
|
|
| Net Cash – Investing activities | | | (105 | ) | | |
(29
|
)
|
| Financing Activities | | | | | | |
|
Repurchase of common stock
| | | (15 | ) | | |
(1
|
)
|
|
Proceeds from exercise of employee stock options
| | | — | | | |
16
| |
|
Dividends paid
| | | (22 | ) | | |
(19
|
)
|
|
Other, net
| | | 1 |
| | |
(6
|
)
|
| Net Cash – Financing activities | | | (36 | ) | | |
(10
|
)
|
| Effect of exchange rate changes on cash | | | (8 | ) | | |
7
|
|
|
Net change in cash and cash equivalents
| | | (129 | ) | | |
29
| |
|
Cash and cash equivalents at beginning of year
| | | 504 |
| | |
318
|
|
| Cash and cash equivalents at end of period | | | $ | 375 |
| | |
$
|
347
|
|
| Supplemental disclosure of cash flow information: | | | | | | |
|
Cash paid during the period for:
| | | | | | |
|
Interest
| | | $ | 11 | | | |
$
|
11
| |
|
Income taxes (net of refunds received)
| | | $ | 27 | | | |
$
|
18
| |
| | | | | | | | | |
|
Xylem Inc. Non-GAAP Measures
Management views key performance indicators including revenue, gross
margins, segment operating income and margins, orders growth, free cash
flow, working capital, and backlog, among others. In addition, we
consider certain measures to be useful to management and investors
evaluating our operating performance for the periods presented, and
provide a tool for evaluating our ongoing operations, liquidity and
management of assets. This information can assist investors in assessing
our financial performance and measures our ability to generate capital
for deployment among competing strategic alternatives and initiatives.
These metrics, however, are not measures of financial performance under
GAAP and should not be considered a substitute for revenue, operating
income, net income, earnings per share (basic and diluted) or net cash
from operations as determined in accordance with GAAP. We consider the
following non-GAAP measures, which may not be comparable to similarly
titled measures reported by other companies, to be key performance
indicators:
“Organic revenue" and "Organic orders” defined as
revenue and orders, respectively, excluding the impact of foreign
currency fluctuations, intercompany transactions, and contributions from
acquisitions and divestitures. Divestitures include sales of portions of
our business that did not meet the criteria for classification as a
discontinued operation or insignificant portions of our business that we
did not classify as a discontinued operation. The period-over-period
change resulting from foreign currency fluctuations assumes no change in
exchange rates from the prior period.
“Constant currency” defined as financial results adjusted for
currency translation impacts by translating current period and prior
period activity using the same currency conversion rate. This approach
is used for countries whose functional currency is not the U.S. dollar.
“EBITDA” defined as earnings before interest, taxes,
depreciation, amortization expense, and share-based compensation.
“Adjusted EBITDA” reflects the adjustment to EBITDA to exclude for
non-recurring separation costs associated with the Xylem spin-off from
ITT Corporation (not excluded for 2013) as well as non-recurring
restructuring and realignment costs.
"Adjusted Operating Income", "Adjusted Segment Operating Income", and
“Adjusted EPS” defined as operating income and earnings per share,
adjusted to exclude non-recurring separation costs associated with the
Xylem spin-off from ITT Corporation (not excluded for 2013),
non-recurring restructuring and realignment costs and tax-related
special items.
“Free Cash Flow” defined as net cash from operating activities,
as reported in the Statement of Cash Flow, less capital expenditures as
well as adjustments for other significant items that impact current
results which management believes are not related to our ongoing
operations and performance. Our definition of free cash flows does not
consider non-discretionary cash payments, such as debt.
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Xylem Inc. Non-GAAP Reconciliation
|
|
Reported vs. Organic & Constant Currency Order Growth
|
|
($ Millions)
|
| |
| | |
| | |
|
| | (As Reported - GAAP) | | | (As Adjusted - Organic) | | | Constant Currency |
| | | | |
(A)
| | |
(B)
| | | | | |
(C)
| | |
(D)
| | |
(E)
| | |
(F) = B+C+D+E
| | |
(G) = F/A
| | |
(H) = (B + D) / A
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | |
Change
| | |
% Change
| | | |
| | | | | | | |
Change
| | |
% Change
| | | | | | | | | | | |
Adj.
| | |
Adj.
| | | |
| | | | | | | |
2013 v.
| | |
2013 v.
| | |
Acquisitions /
| | | | | | | | |
2013 v.
| | |
2013 v.
| | | |
| |
Orders
| | |
Orders
| | |
2012
| | |
2012
| | |
Divestitures
| | |
FX Contribution
| | |
Eliminations
| | |
2012
| | |
2012
| | |
|
| |
2013
| | |
2012
| | | | | | | | | | | | | | | | | | | | | | | | |
| Quarter Ended March 31, 2013 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
| Xylem Inc. | |
962
| | |
1,004
| | |
(42
|
)
| | |
-4.2
|
%
| | |
(26
|
)
| | |
2
| | |
-
| | | |
(66
|
)
| | |
-6.6
|
%
| | |
-4.0
|
%
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Water Infrastructure
| |
601
| | |
638
| | |
(37
|
)
| | |
-5.8
|
%
| | |
(26
|
)
| | |
2
| | |
-
| | | |
(61
|
)
| | |
-9.6
|
%
| | |
-5.5
|
%
|
|
Applied Water
| |
378
| | |
382
| | |
(4
|
)
| | |
-1.0
|
%
| | |
-
| | | |
-
| | |
(1
|
)
| | |
(5
|
)
| | |
-1.3
|
%
| | |
-1.0
|
%
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
|
Note: Due to rounding the sum of segment amounts may not agree to
Xylem totals.
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
|
|
|
Xylem Inc. Non-GAAP Reconciliation
|
|
Reported vs. Organic & Constant Currency Revenue
|
|
($ Millions)
|
|
|
|
|
|
|
|
|
|
| | (As Reported - GAAP) | | | (As Adjusted - Organic) | | | Constant Currency |
| | |
|
|
(A)
|
|
|
(B)
|
|
| | | |
(C)
|
|
|
(D)
|
|
|
(E)
|
|
|
(F) = B+C+D+E
|
|
|
(G) = F/A
| | |
(H) = (B + D) / A
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | |
Change
| | |
% Change
| | | |
| | | | | | | |
Change
| | |
% Change
| | | | | | | | | | | |
Adj.
| | |
Adj.
| | | |
| | | | | | | |
2013 v.
| | |
2013 v.
| | |
Acquisitions /
| | | | | | | | |
2013 v.
| | |
2013 v.
| | | |
| |
Revenue
| | |
Revenue
| | |
2012
| | |
2012
| | |
Divestitures
| | |
FX Contribution
| | |
Eliminations
| | |
2012
| | |
2012
| | |
|
| |
2013
| | |
2012
| | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
| Quarter Ended March 31, 2013 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
| Xylem Inc. | |
879
| | |
925
| | |
(46
|
)
| | |
-5.0
|
%
| | |
(23
|
)
| | |
2
| | |
-
| | | |
(67
|
)
| | |
-7.2
|
%
| | |
-4.8
|
%
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Water Infrastructure
| |
551
| | |
584
| | |
(33
|
)
| | |
-5.7
|
%
| | |
(23
|
)
| | |
1
| | |
-
| | | |
(55
|
)
| | |
-9.4
|
%
| | |
-5.5
|
%
|
|
Applied Water
| |
345
| | |
355
| | |
(10
|
)
| | |
-2.8
|
%
| | |
-
| | | |
-
| | |
(2
|
)
| | |
(12
|
)
| | |
-3.4
|
%
| | |
-2.8
|
%
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
|
Note: Due to rounding the sum of segment amounts may not agree to
Xylem totals.
|
|
|
|
|
| |
|
| |
|
Xylem Inc. Non-GAAP Reconciliation
|
|
Adjusted Operating Income
|
|
($ Millions)
|
| | |
|
| | | Q1 |
| | | '13 | | | '12 |
|
Total Revenue
| | | | | | |
|
• Total Xylem
| | |
879
| | |
925
|
|
• Water Infrastructure
| | |
551
| | |
584
|
|
• Applied Water
| | |
345
| | |
355
|
|
|
|
|
|
|
|
|
|
Operating Income
| | | | | | |
|
• Total Xylem
| | |
66
| | |
99
|
|
• Water Infrastructure
| | |
42
| | |
75
|
|
• Applied Water
| | |
40
| | |
40
|
| | | | | |
|
|
Operating Margin
| | | | | | |
|
• Total Xylem
| | |
7.5%
| | |
10.7%
|
|
• Water Infrastructure
| | |
7.6%
| | |
12.8%
|
|
• Applied Water
|
|
|
11.6%
|
|
|
11.3%
|
| | | | | |
|
|
Separation Costs
| | | | | | |
|
• Total Xylem
| | |
-
| | |
5
|
|
• Water Infrastructure
| | |
-
| | |
2
|
|
• Applied Water
| | |
-
| | |
1
|
| | | | | |
|
|
Restructuring & Realignment Costs
| | | | | | |
|
• Total Xylem
| | |
12
| | |
-
|
|
• Water Infrastructure
| | |
10
| | |
-
|
|
• Applied Water
| | |
2
| | |
-
|
|
|
|
|
|
|
|
|
|
Adjusted Operating Income*
| | | | | | |
|
• Total Xylem
| | |
78
| | |
104
|
|
• Water Infrastructure
| | |
52
| | |
77
|
|
• Applied Water
| | |
42
| | |
41
|
| | | | | |
|
|
Adjusted Operating Margin*
| | | | | | |
|
• Total Xylem
| | |
8.9%
| | |
11.2%
|
|
• Water Infrastructure
| | |
9.4%
| | |
13.2%
|
|
• Applied Water
|
|
|
12.2%
|
|
|
11.5%
|
| | | | | |
|
*Adjusted Operating Income excludes restructuring & realignment costs in
2013 and excludes non-recurring separation costs in 2012.
|
|
| |
|
| |
| |
|
| |
|
| |
|
| |
| |
|
| |
|
Xylem Inc. Non-GAAP Reconciliation
|
|
Adjusted Diluted EPS
|
|
($ Millions, except per share amounts)
|
|
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | | |
|
| |
|
| | | | |
| | |
|
| | | | | Q1 2012 | | | Q1 2013 |
| | | | | As Reported | | | Adjustments | | | | | Adjusted | | | As Reported | | | Adjustments | | | | | Adjusted |
| |
Total Revenue
| | | |
925
| | | | | | | | | |
925
| | | | |
879
| | | | | | | | | |
879
| |
| |
Operating Income
| | | |
99
| | | | |
5
| | |
a
| | | |
104
| | | | |
66
| | | | |
12
| | |
c
| | | |
78
| |
| |
Operating Margin
| | | | 10.7 | % | | | | | | | | | 11.2 | % | | | | 7.5 | % | | | | | | | | | 8.9 | % |
| |
Interest Expense
| | | |
(14
|
)
| | | | | | | | |
(14
|
)
| | | |
(13
|
)
| | | | | | | | |
(13
|
)
|
| |
Other Non-Operating Income (Expense)
| | |
|
(1
|
)
| | |
| | | | |
|
(1
|
)
| | |
|
(2
|
)
| | |
| | | | |
|
(2
|
)
|
| |
Income before Taxes
| | |
|
84
|
| | |
|
5
|
| | | | |
|
89
|
| | | |
51
| | | | |
12
| | | | | | |
63
| |
| |
Provision for Income Taxes
| | |
|
(21
|
)
| | |
|
(1
|
)
| |
b
| | |
|
(22
|
)
| | |
|
(10
|
)
| | |
|
(3
|
)
| |
d
| | |
|
(13
|
)
|
| |
Net Income
| | |
|
63
|
| | |
|
4
|
| | | | |
|
67
|
| | |
|
41
|
| | |
|
9
|
| | | | |
|
50
|
|
| |
Diluted Shares
|
|
|
|
185.9
|
|
|
|
|
|
|
|
|
|
185.9
|
|
|
|
|
186.4
|
|
|
|
|
|
|
|
|
|
186.4
|
|
| | Diluted EPS |
|
| $ | 0.34 |
|
|
| $ | 0.02 |
|
|
|
|
| $ | 0.36 |
|
|
| $ | 0.22 |
|
|
| $ | 0.05 |
|
|
|
|
| $ | 0.27 |
|
| | | | | | | | | | | | | | | | | | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | | |
|
|
a
| |
One time separation costs
| | | | | | | | | | | | | | | | | | | | | | |
|
b
| |
Net tax impact of separation costs
| | | | | | | | | | | | | | | | | | | | | | |
|
c
| |
Restructuring & realignment costs
| | | | | | | | | | | | | | | | | | | | | | |
|
d
| |
Tax impact of restructuring & realignment costs
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
|
|
|
| |
|
| |
|
Xylem Inc. Non-GAAP Reconciliation
|
|
Net Cash - Operating Activities vs. Free Cash Flow
|
|
Three Months Ended March 31, 2013 and 2012
|
|
($ Millions)
|
| | | | | |
|
| | | | | |
|
| | |
Three Months Ended
|
| | |
2013
| | |
2012
|
| | | | | |
|
| Net Cash - Operating Activities | | |
20
| | | |
61
| |
| | | | | |
|
|
Capital Expenditures
| | |
(30
|
)
| | |
(31
|
)
|
| | |
| | |
|
|
Free Cash Flow, including separation costs
| | |
(10
|
)
| | |
30
| |
| | | | | |
|
|
Cash Paid for Separation Costs (incl. Capex)
| | |
-
| | | |
11
| |
| | |
| | |
|
| Free Cash Flow, excluding separation costs* | | |
(10
|
)
| | |
41
|
|
| | | | | |
|
|
Net Income
| | |
41
| | | |
63
| |
| | | | | |
|
|
Separation Costs, net of tax (incl. tax friction)
| | |
-
|
| | |
4
|
|
| | | | | |
|
| Net Income, excluding separation costs* | | |
41
|
| | |
67
|
|
| | | | | |
|
| Free Cash Flow Conversion | | |
-24
|
%
| | |
61
|
%
|
| | | | | |
|
* Separation costs are not excluded in 2013
|
|
| |
|
| |
| |
|
| |
|
| |
|
| |
| |
|
| |
|
Xylem Inc. Non-GAAP Reconciliation
|
|
Guidance
|
|
($ Millions, except per share amounts)
|
|
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
|
| | | | | | | | | | | | | | | | Illustration of Mid Point Guidance |
| | 2013 Guidance |
| | | | |
| | |
|
| | | | | FY '12 | | | FY '13 |
| | | | | As Reported | | | Adjustments | | | | | Adjusted | | | As Projected | | | Adjustments | | | | | Adjusted |
| |
Total Revenue
| | | |
3,791
| | | | | | | | | |
3,791
| | | | |
3,925
| | | | | | | | | |
3,925
| |
| |
Segment Operating Income
| | | |
512
| | | | |
30
| | |
a
| | | |
542
| | | | |
484
| | | | |
65
| | |
d
| | | |
549
| |
| |
Segment Operating Margin
| | | |
13.5
|
%
| | | | | | | | |
14.3
|
%
| | | |
12.3
|
%
| | | | | | | | |
14.0
|
%
|
| |
Corporate Expense
| | |
|
69
|
| | |
|
(16
|
)
| |
b
| | |
|
53
|
| | |
|
59
|
| | |
|
-
|
| | | | |
|
59
|
|
| |
Operating Income
| | |
|
443
|
| | |
|
46
|
| | | | |
|
489
|
| | |
|
425
|
| | |
|
65
|
| | | | |
|
490
|
|
| |
Operating Margin
| | | |
11.7
|
%
| | | | | | | | |
12.9
|
%
| | | |
10.8
|
%
| | | | | | | | |
12.5
|
%
|
| |
Interest Expense
| | | |
(55
|
)
| | | | | | | | |
(55
|
)
| | | |
(55
|
)
| | | | | | | | |
(55
|
)
|
| |
Other Non-Operating Income (Expense)
| | |
|
-
|
| | |
| | | | |
|
-
|
| | |
|
(2
|
)
| | |
| | | | |
|
(2
|
)
|
| |
Income before Taxes
| | |
|
388
|
| | |
|
46
|
| | | | |
|
434
|
| | | |
368
| | | | |
65
| | | | | | |
433
| |
| |
Provision for Income Taxes
| | |
|
(91
|
)
| | |
|
(13
|
)
| |
c
| | |
|
(104
|
)
| | |
|
(72
|
)
| | |
|
(19
|
)
| |
c
| | |
|
(91
|
)
|
| |
Net Income
| | |
|
297
|
| | |
|
33
|
| | | | |
|
330
|
| | |
|
296
|
| | |
|
46
|
| | | | |
|
342
|
|
| |
Diluted Shares
|
|
|
|
186.2
|
|
|
|
|
|
|
|
|
|
186.2
|
|
|
|
|
186.4
|
|
|
|
|
|
|
|
|
|
186.4
|
|
| | Diluted EPS |
|
| $ | 1.59 |
|
|
| $ | 0.18 |
|
|
|
|
| $ | 1.77 |
|
|
| $ | 1.59 |
|
|
| $ | 0.25 |
|
|
|
|
| $ | 1.84 |
|
| | | | | | | | | | | | | | | | | | | | | | | |
|
|
a
| |
One time separation, restructuring and realignment costs incurred at
the segment level
|
|
b
| |
One time separation, restructuring and realignment costs incurred at
the corporate level
|
|
c
| |
Net tax impact of above items, plus the addition of special tax items
|
|
d
| |
Restructuring and realignment costs incurred at the segment level
|
| |
|
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
| Xylem Inc. Non-GAAP Reconciliation |
| Adjusted Operating Income |
| ($ Millions) |
| | | | | | | | | | | | | | | | | |
|
| | | | | | | | | | | | | | | | | |
|
| | |
| | |
| | |
| | |
| | |
| | | Mid Point Guidance |
| | | 2008 | | | 2009 | | | 2010 | | | 2011 | | | 2012 | | | 2013E |
| | | | | | | | | | | | | | | | | |
|
| Revenue | | |
3,291
| | | |
2,849
| | | |
3,202
| | | |
3,803
| | | |
3,791
| | | |
3,925
| |
| | |
| | |
| | |
| | |
| | |
| | |
|
| Operating Income | | |
315
|
| | |
276
|
| | |
388
|
| | |
395
|
| | |
443
|
| | |
425
|
|
| | | | | | | | | | | | | | | | | |
|
| Operating Margin | | | 9.6 | % | | | 9.7 | % | | | 12.1 | % | | | 10.4 | % | | | 11.7 | % | | | 10.8 | % |
| | | | | | | | | | | | | | | | | |
|
| Restructuring & Realignment | | |
41
| | | |
31
| | | |
15
| | | |
-
| | | |
24
| | | |
65
| |
| Separation Costs | | |
-
| | | |
-
| | | |
-
| | | |
87
| | | |
22
| | | |
-
| |
| | |
| | |
| | |
| | |
| | |
| | |
|
| Adjusted Operating Income | | |
356
|
| | |
307
|
| | |
403
|
| | |
482
|
| | |
489
|
| | |
490
|
|
| | | | | | | | | | | | | | | | | |
|
| Adjusted Operating Margin | | | 10.8 | % | | | 10.8 | % | | | 12.6 | % | | | 12.7 | % | | | 12.9 | % | | | 12.5 | % |
| | | | | | | | | | | | | | | | | |
|
| Standalone Costs | | |
-
| | | |
-
| | | |
-
| | | |
5
| | | |
28
| | | |
-
| |
| | |
| | |
| | |
| | |
| | |
| | |
|
| Adj. Operating Income, excl. Standalone Costs | | |
356
|
| | |
307
|
| | |
403
|
| | |
487
|
| | |
517
|
| | |
490
|
|
| | | | | | | | | | | | | | | | | |
|
| Adjusted Operating Margin, excl. Standalone Costs | | | 10.8 | % | | | 10.8 | % | | | 12.6 | % | | | 12.8 | % | | | 13.6 | % | | | 12.5 | % |

Contacts:
Xylem
Media:
Tom Glover, +1-914-323-5891
tom.glover@xyleminc.com
or
Investors:
Phil
DeSousa, +1-914-323-5930
phil.desousa@xyleminc.com
Source: Xylem Inc.
© 2026 Canjex Publishing Ltd. All rights reserved.